Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders
Author:
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1038/bjp.2008.204/fullpdf
Reference130 articles.
1. Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412;Aichberger;Blood,2007
2. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology;Akin;J Mol Diagn,2006
3. Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit;Akin;Exp Hematol,2003
4. A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib;Akin;Blood,2004
5. The biology of Kit in disease and the application of pharmacogenetics;Akin;J Allergy Clin Immunol,2004
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tyrosine kinases: multifaceted receptors at the intersection of several neurodegenerative disease-associated processes;Frontiers in Dementia;2024-08-16
2. c-KIT inhibitors reduce pathology and improve behavior in the Tg(SwDI) model of Alzheimer’s disease;Life Science Alliance;2024-07-15
3. Exosome regulation of immune response mechanism: Pros and cons in immunotherapy;Bioactive Materials;2024-02
4. CREB Is Indispensable to KIT Function in Human Skin Mast Cells—A Positive Feedback Loop between CREB and KIT Orchestrates Skin Mast Cell Fate;Cells;2023-12-24
5. Genome Variation Map of Domestic Qinghai-Tibet Plateau Yaks by SLAF-Seq Reveals Genetic Footprint during Artificial Selection;Animals;2023-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3